Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: CHEMOGENICS BIOPHARMA, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-09-16 to 2024-10-15
Current total value of award: $240000
Description: NCATS IS IN NEED OF CUSTOM SYNTHESIS AND BIOANALYTICAL SERVICES IN INTERNAL PROJECTS FOCUSED ON DEVELOPING SMALL MOLECULE INHIBITORS OF PHYSIOLOGICAL SMALL MOLECULE METHYLTRANSFERASES